BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 8327871)

  • 1. Leprosy today.
    Noordeen SK
    Schweiz Med Wochenschr; 1993 Jun; 123(24):1228-36. PubMed ID: 8327871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elimination of leprosy as a public health problem: progress and prospects.
    Noordeen SK
    Bull World Health Organ; 1995; 73(1):1-6. PubMed ID: 7704919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of leprosy/Hansen's disease in the early 21st century.
    Worobec SM
    Dermatol Ther; 2009; 22(6):518-37. PubMed ID: 19889136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The imperatives of leprosy treatment in the pre- and post-global leprosy elimination era: appraisal of changing the scenario to current status.
    Sehgal VN; Sardana K; Dogra S
    J Dermatolog Treat; 2008; 19(2):82-91. PubMed ID: 17852638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
    de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hansen's disease (Leprosy): current and future pharmacotherapy and treatment of disease-related immunologic reactions.
    Legendre DP; Muzny CA; Swiatlo E
    Pharmacotherapy; 2012 Jan; 32(1):27-37. PubMed ID: 22392826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidrug therapy in leprosy.
    Manglani PR; Arif MA
    J Indian Med Assoc; 2006 Dec; 104(12):686-8. PubMed ID: 17474286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Eradication of leprosy and public health. Vaccination and multidrug therapy].
    Janaszek W
    Przegl Epidemiol; 2002; 56(4):577-86. PubMed ID: 12666583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of multidrug therapy in multibacillary leprosy: a long-term follow-up of 34 multibacillary leprosy patients treated with multidrug regimens till skin smear negativity.
    Shaw IN; Christian M; Jesudasan K; Kurian N; Rao GS
    Lepr Rev; 2003 Jun; 74(2):141-7. PubMed ID: 12862255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The 69th annual meeting special lecture. Present situation of leprosy].
    Ito T
    Kekkaku; 1995 May; 70(5):361-3. PubMed ID: 7783397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leprosy. An update: definition, pathogenesis, classification, diagnosis, and treatment.
    Eichelmann K; González González SE; Salas-Alanis JC; Ocampo-Candiani J
    Actas Dermosifiliogr; 2013 Sep; 104(7):554-63. PubMed ID: 23870850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic regimens in leprosy.
    Pattyn SR
    Verh K Acad Geneeskd Belg; 1990; 52(4):301-10; discussion 310-2. PubMed ID: 2077778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response to treatment by multidrug regimens in the THELEP controlled clinical drug trials. Subcommittee on Clinical Trials of the Chemotherapy of Leprosy (THELEP) Scientific Working Group of the UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases.
    Lepr Rev; 1996 Dec; 67(4):260-79. PubMed ID: 9033197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global review of multidrug therapy (MDT) in leprosy.
    Noordeen SK; Lopez Bravo L; Daumerie D
    World Health Stat Q; 1991; 44(1):2-15. PubMed ID: 2068821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multidrug therapy--the pathway for global leprosy elimination.
    al-Qubati Y; al-Kubati AS
    Indian J Lepr; 2000; 72(4):477-90. PubMed ID: 11212482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leprosy: an urgent need to step up use of MDT in Africa.
    Mcdougall AC
    Afr Health; 1992 Jan; 14(2):31, 34-5. PubMed ID: 12285084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A retrospective study of the effect of modified multi-drug therapy in Nepali leprosy patients following the development of adverse effects due to dapsone.
    Sapkota BR; Shrestha K; Pandey B; Walker SL
    Lepr Rev; 2008 Dec; 79(4):425-8. PubMed ID: 19274989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relapses in leprosy patients treated with rifampicin plus dapsone after varying periods of dapsone monotherapy.
    Li HY; Ran SP; Weng XM; Li TG; Deng XH; Li FT
    Indian J Lepr; 2001; 73(1):1-10. PubMed ID: 11326592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WHO Expert Committee on Leprosy.
    World Health Organ Tech Rep Ser; 1998; 874():1-43. PubMed ID: 9627517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of PCR mediated amplification of DNA and the classical methods for detection of Mycobacterium leprae in different types of clinical samples in leprosy patients and contacts.
    Torres P; Camarena JJ; Gomez JR; Nogueira JM; Gimeno V; Navarro JC; Olmos A
    Lepr Rev; 2003 Mar; 74(1):18-30. PubMed ID: 12669929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.